Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14551 - 14575 of 14677 in total
Experimental
SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes.
Investigational
ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant reductions in LDL-cholesterol.
Investigational
Experimental
CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
Experimental
Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational
XL418 is a novel anticancer compound.
Investigational
Displaying drugs 14551 - 14575 of 14677 in total